.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Johnson and Johnson
Daiichi Sankyo
Baxter
Harvard Business School
Federal Trade Commission
Healthtrust
Boehringer Ingelheim
Covington

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075919

« Back to Dashboard

NDA 075919 describes MOMETASONE FUROATE, which is a drug marketed by Fougera Pharms, G And W Labs, Glenmark Generics, Taro, Tolmar, Perrigo Israel, Perrigo New York, Amneal Pharms, and Apotex Inc, and is included in nineteen NDAs. It is available from eighteen suppliers. Additional details are available on the MOMETASONE FUROATE profile page.

The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There are twenty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

Summary for 075919

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 075919

Medical Subject Heading (MeSH) Categories for 075919

Suppliers and Packaging for NDA: 075919

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 075919 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0272 0168-0272-30 1 BOTTLE in 1 CARTON (0168-0272-30) > 30 mL in 1 BOTTLE
MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 075919 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0272 0168-0272-60 1 BOTTLE in 1 CARTON (0168-0272-60) > 60 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.1%
Approval Date:Nov 29, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Federal Trade Commission
US Army
Chubb
Cipla
Fish and Richardson
Cerilliant
Colorcon
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot